Advancing excellence in laboratory medicine for better healthcare worldwide

IFCC - Scientific Division (SD)


SD Executive Committee Meeting,  General Conference Brussels - October 2022


From right to left: 

Ian Young - ICHCLR Observer; Christa Cobbaert - Chair; Konstantinos Makris - Vice-Chair; R.D. Josephs - BIPM Observer; Michael Rottmann- Corporate Members Representative (until December 2022); Greg Miller - JCTLM Consultant; Garry John - Secretary; Liesbet Drepez - JRC Observer; Philippe Gillery - Chair (until December 2022); Paola Bramati - IFCC Office. 

SD Executive Committee (SD-EC) biographies



The Scientific Division (SD)

A Committee on Standards was established in 1966 "to instigate and promote theoretical and practical developments in the field of standards and standardisation in clinical chemistry - in its broadest sense." During its first decade, the main efforts of the Committee were directed toward (1) analytical nomenclature, (2) reference materials and methods, and (3) quality control. Its achievements during this period are illustrated by the list of publications on these topics. Following a Council decision in 1978, efforts have been made to extend its work to include more subjects of interest both to clinicians and clinical chemists and laboratorians. Accordingly, the name of the Committee was changed to the Scientific Committee and later to the Scientific Division.

The Division and its activities are managed by an Executive Committee. This Committee is responsible for (1) developing a mission statement, (2) developing strategy and tactics, (3) initiating and managing projects, and (4) generating and adhering to its Terms of Reference.

Mission Statement

The mission of the SD is to advance the science of Clinical Chemistry and Laboratory Medicine and to apply it to the practice of Clinical Laboratory Science. 

SD Strategy

According to the Statutes of IFCC, the Federation exists to advance the science and practice of Clinical Chemistry and to further its application in the provision of health services and the practice of medicine. The goals to which the Scientific Division is committed are to:

  • Identify research areas of relevance to Clinical Chemistry and Laboratory Medicine and assist the transfer of research results to the profession.
  • Identify scientific and technological problems in current practice and provide solutions and guidelines on how to resolve them.
  • Facilitate the development and transfer of technical innovations to clinical laboratory professionals and clinicians.
  • Facilitate the development and implementation of diagnostic strategies.
  • Establish standards for scientific and technical aspects of good laboratory practice.
  • Facilitate the development of reference measurement processes and the production of reference materials
  • Establish networks of reference laboratories
  • Respond to scientific and technical needs of IFCC Member Societies, IFCC Corporate Members and external agencies.
  • Participate actively in the scientific programmes of IFCC congresses and other scientific meetings.
  • Ensure the quality of IFCC scientific documents.
  • Organise Master Discussions

SD Projects

The SD initiates and manages projects with its own resources or through its Committees and Working Groups. Work is conducted in cooperation with other IFCC units and with relevant National and International Organisations. The SD ensures that each of its Committees and Working Groups are functioning under clear terms of reference together with an agreed schedule of activity. The SD will assist in the development of the project proposals, and will undertake an annual review of progress and review and approve any documents that result from the work.


SD Executive Committee (SD-EC)

Name Position Country Term Time in Office
C.M. Cobbaert Chair NL 1st  2023 01 - 2025 12
K. Makris Vice-Chair GR 1st 2023 01 - 2025 12
G. John Secretary UK 1st 2021 03 - 2023 12
B. Das Member IN 2nd 2021 01 - 2023 12
V. Delatour Member FR 1st 2023 01 - 2025 12
H. Vesper Member US 1st 2023 01 - 2025 12
S. Wittfooth Member / Junior FI 1st 2023 01 - 2025 12
C. Vogl Corporate Member DE 1st 2023 01 - 2025 12
R.D. Josephs BIPM Observer FR    
L. Deprez European Commission/JRC Observer BE    
I. Young ICHCLR Observer UK    
G. Miller JCTLM Chair / SD Consultant US    
C. Burns NIBSC Consultant UK    
Y. Zhen NIFDC Observer CN    
K. Phinney NIST Consultant US    


Chairs of Scientific Division's Committees and Working Groups



8.2.06 Nomenclature, Properties and Units (C-NPU) in collaboration with International Union of Pure and Applied Chemistry (IUPAC) Y.B.L. Hansen (DK)
8.2.11 Molecular Diagnostics (C-MD) P. Ahmad-Nejad (DE)
8.2.23 Traceability in Laboratory Medicine (C-TLM) A. Kessler (DE)
8.2.24 Reference Intervals and Decision Limits (C-RIDL) T. Streichert (DE)
8.2.25 Standardization of Thyroid Function Tests (C-STFT) K. Van Uytfanghe (BE)
8.2.26 Bone Metabolism (C-BM) E. Cavalier (BE)

Working Groups

8.3.35 Standardisation of Hemoglobin A2 (WG-HbA2) - Joint Working Group with ICSH (International Council for Standardization in Haematology) G. Arsene (DE)
8.3.36 Carbohydrate-Deficient Transferrin (WG-CDT) J. Deenmamode (UK)
8.3.39 Standardisation of Albumin Assay in Urine (WG-SAU) - in collaboration with NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases
J. Seegmiller (US)
8.3.41 Growth-Hormone (WG-hGH) M. Vos (NL)
8.3.42 Standardisation of Insulin Assays (WG-SIA) in collaboration with American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) R. Little (US)
8.3.43. Standardisation of Troponin I (WG-TNI) C. Swart (DE)
8.3.45 Harmonization of Autoantibody Testing (WG-HAT)

J. Sheldon (UK)

8.3.49 CSF Proteins (WG-CSF) J. Gobom (SE)
8.3.51 Commutability in Metrological Traceability (WG-CMT) G. Miller (US)
8.3.53 Immunosuppressive Drugs (WG-ID) C. Seger (CH)
8.3.54 Apolipoproteins by Mass Spectrometry (WG-APO MS) L.R. Ruhaak (NL)
8.3.55 Pancreatic Enzymes (WG-PE) A. Staaden (DE)
8.3.56 Fecal Immunochemical Testing (WG-FIT) S. Benton (UK)
8.3.57 Cell free DNA and related circulating biomarkers (WG-cfDNA) R. van Schaik (NL)
8.3.58 Procalcitonin (WG-PCT) V. Delatour (FR)
8.3.60 Continuous Glucose Monitoring (WG-CGM) G. Freckmann (DE)
8.3.61 Development of a Reference Measurement System for sustainable PT/INR Standardization (WG PT/INR) C. Cobbaert (NL)
8.3.62 Neonatal Bilirubin (WG-NB) - in cooperation with IFCC Emerging Technologies Division (ETD) L. Mackay (AU) / R. Greaves (AU)
8.3.64 Standardisation of Natriuretic Peptides (WG-NP)  A. Reid (UK)






SD Executive Committe's contacts 



Prof. Christa M. COBBAERT
Clinical Chemist Head of the Department
of Clinical Chemistry
Leiden University Medical Center
Postbus 9600 Postzone E2-P
2300 RC Leiden - The Netherlands
Tel: +31 71 5262278/+31 71 5264483
Fax : +31 71 52666753
E-mail: C.M.Cobbaert@lumc


Dr. Konstantinos MAKRIS
Clinical Biochemist
Clinical Biochemistry Department
KAT General Hospital
2 Nikis street, 14561
Kifissia, Athens - Greece
Phone: +30-213-2086701
Mobile: +30-6972207867


Prof. Garry JOHN
Department of Clinical Biochemistry and Immunology
Norfolk and Norwich University Hospital
Norwich  NR4 7UY
Tel: +44 01603 286933


Dr. Barnali DAS
Lead Consultant, Biochemistry & Immunology
Kokilaben Dhirubhai Ambani Hospital &
Medical Research Institute,
Four Bunglows, Andheri (West)
Mumbai 400053 - India
Tel: +91-22-30970734
Mobile: +91-9324349519


Dr.  Vincent DELATOUR
Reseach Director Bioanalysis
Laboratoire National de Métrologie et d’Essais (LNE)
1, Gaston Boissier
75724 Paris - France
Tel: +33 (0) 140 434 075


Dr. Hubert VESPER
Director, Clinical Standardization Programs
Chief, Protein Biomarker and Lipid Reference Laboratory
Clinical Chemistry Branch
Division of Laboratory Sciences
Centers for Disease Control and Prevention
4770 Buford Hwy NE MS F25
Atlanta, GA 30341 - USA
E-mail:  /


Assistant Professor of Biotechnology
Department of Life Technologies
Faculty of Technology
20014 University of Turku


Dr. Christian VOGL
Roche Diagnostics GmbH
Team Lead Immunoassay Development
Indication Area Lead Anemia, Bonemaker, Immunosuppressives
Nonnenwald 2
82377 Penzberg



Principal Chemist
Pavillon de Breteuil
92312 Sèvres Cedex
Tel.: + 33 (0)1 45 07 70 55



Dr. Liesbet DEPREZ
Project Officer
European Commission
Directorate General Joint Research Centre
Directorate F – Health, Consumers and Reference Materials - Reference Materials Unit
Retieseweg 111
2440 Geel - Belgium
Tel: +32 (0)14 57 16 34



Prof. Ian S. YOUNG
Professor of Medicine
Queen's University Belfast
The Center for Public Health
1st floor - ICS B block
Royal Victoria Hospital
Grosvenor Road
BT12 GBJ - Belfast - UK
Tel: +44 02890632743



Professor of Pathology
Co-Director of Clinical Chemistry
Director of Pathology Information Systems
Virginia Commonwealth University Health System
Richmond, VA 23298-0286 - USA
Tel:  +1.804.828.0375



Dr. Chris BURNS
Head, Biotherapeutics Division
National Institute for Biological Standards and Control (NIBSC)
A Centre of the MHRA, Blanche Lane
South Mimms, Potters Bar
Hertfordshire, EN6 3QG - UK
Tel: 01707 641247



Dr. Yang ZHEN
Deputy Director General
National Institutes for Food and Drug Controls (NIFDC)


Dr. Karen W. PHINNEY
Leader, Bioanalytical Science Group
Biomolecular Measurement Division
National Institute of Standards and Technology (NIST)
100 Bureau Drive, Stop 8314
Gaithersburg, MD 20899-8314 - USA
Tel.: +1 (301) 975-4457




Website developed by Insoft